Vorapaxar: FDA Panel Backs Blood Clot-Preventing Drug For Heart Attack Survivors
Category: WELLNESS
The panel voted 10-1 in favor of the drug, which would, if approved, be sold under the brand name Zontivity. The FDA is not
By Reuters, Reuters, 2014-01-15